Drug Trial Radar · NCT00671567
Ramelteon in Adults With Chronic Insomnia
Last checked: Nov 20, 2026Latest source record: Nov 20, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
848
Actual
Start
Dec 2002
Primary completion
Sep 2003
Study completion Sep 2003
Sponsor
- Lead sponsor
- TakedaTakeda (TAK)
- Sponsor type
- Industry
- First posted
- May 5, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the safety and efficacy of Ramelteon, once daily (QD), in adult subjects with chronic insomnia.
Conditions
- Chronic Insomnia
Interventions
RamelteonDrug
Ramelteon, 8 mg, tablets, orally, once daily for up to 5 weeks.
RamelteonDrug
Ramelteon, 16 mg, tablets, orally, once daily for up to 5 weeks.
PlaceboDrug
Ramelteon placebo-matching tablets, orally, once daily for up to 5 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Subjective Sleep Latency per subject diary, from Nights 1 through 7 of double-blind treatment.Time frame: Weeks 1, 2, 3, 4, and 5 or Final Visit
Locations
70 sites in 1 country. Site status is shown where the registry gives one.
Site not named
Birmingham, Alabama
Site not named
Mobile, Alabama
Site not named
Mesa, Arizona
Site not named
Phoenix, Arizona
Site not named
Scottsdale, Arizona
Site not named
Tempe, Arizona
Site not named
Hot Springs, Arkansas
Site not named
Little Rock, Arkansas
Site not named
Anaheim, California
Site not named
Chula Vista, California
Site not named
Irvine, California
Site not named
La Mesa, California
Site not named
Newport Beach, California
Site not named
Northridge, California
Site not named
Oakland, California
Site not named
Redlands, California
Site not named
Spring Valley, California
Site not named
Colorado Springs, Colorado
Site not named
Denver, Colorado
Site not named
Clearwater, Florida
Site not named
Hollywood, Florida
Site not named
Jacksonville, Florida
Site not named
Longwood, Florida
Site not named
Pembroke Pines, Florida
Site not named
Safety Harbor, Florida
Site not named
St. Petersburg, Florida
Site not named
Tampa, Florida
Site not named
Vero Beach, Florida
Site not named
West Palm Beach, Florida
Site not named
Winter Park, Florida
Site not named
Atlanta, Georgia
Site not named
Blairsville, Georgia
Site not named
Decatur, Georgia
Site not named
Macon, Georgia
Site not named
Marietta, Georgia
Site not named
Arlington Heights, Illinois
Site not named
Chicago, Illinois
Site not named
Danville, Indiana
Site not named
Evansville, Indiana
Site not named
Shawnee Mission, Kansas
Showing 40 of 70 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.